A larger study evaluating sotorasib with normal chemotherapy for Highly developed NSCLC is at present below way. Other reports are testing sotorasib together with other cancer treatments.  Treatment with glucagon-like peptide-one receptor agonists and incidence of dementia: Facts from pooled double-blind randomized controlled trials and nationwide illness and prescription registers. https://peterp888coz0.wikistatement.com/user